Quality of Life in Cancer: Definition, Purpose, and Method of Measurement
- 1 January 1993
- journal article
- review article
- Published by Informa UK Limited in Cancer Investigation
- Vol. 11 (3), 327-336
- https://doi.org/10.3109/07357909309024860
Abstract
Over the past 20 years, changes within medicine and society have encouraged an expansion in conceptualizing and evaluating the goals and important outcomes of medical treatments. In evaluating the care of people with cancer and other chronic illnesses, a major part of the expansion has been the inclusion of means to assess the quality of life in addition to the quantity of life associated with various treatments. This paper presents a review of the current literature on quality-of-life assessment in oncology research and practice. The review is organized around current thinking about the definition of quality of life, the purpose of quality-of-life measurement, the method of assessment, and the competing advantages and disadvantages of disease-specific versus general health outcome measurement. Recommendations for proceeding with quality-of-life measurement in oncology are provided to encourage increased attention to the need to remain closely tied to a theoretical construct.Keywords
This publication has 38 references indexed in Scilit:
- The Medical Outcomes StudyJAMA, 1989
- Functional Status and Well-being of Patients With Chronic ConditionsJAMA, 1989
- The functioning and well-being of depressed patients. Results from the Medical Outcomes StudyJAMA, 1989
- Quality of Life End Points in Cancer Clinical Trials: Review and RecommendationsJNCI Journal of the National Cancer Institute, 1989
- Improving the Quality of Life during Chemotherapy for Advanced Breast CancerNew England Journal of Medicine, 1987
- Cancer Inventory of Problem SituationsJournal of Psychosocial Oncology, 1983
- Measuring and analysing quality of life in cancer clinical trials: A reviewStatistics in Medicine, 1983
- The Sickness Impact Profile: Development and Final Revision of a Health Status MeasureMedical Care, 1981
- The relationship of plasma 7α-hydroxy dehydroepiandrosterone to disease stage and adrenal androgens in breast cancer patientsEuropean Journal of Cancer (1965), 1980
- The Sickness Impact Profile: Validation of a Health Status MeasureMedical Care, 1976